Current Research Studies


BE-BALANCED is an exercise program for women diagnosed with ovarian cancer and have completed primary treatment(s). For more information, please click here.

  • BE-FIT : Breast Cancer & Endocrine Therapy FITness

BE-FIT  is an exercise program for women diagnosed with breast cancer and currently receiving endocrine therapy. For more information, please click here.

  • Understanding people’s preferences for physiotherapy after breast cancer surgery

We are doing a study to understand what people who have had surgery for breast cancer think about different physiotherapy programs. For more information, please click here.

  • Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr: the ACTIVATE trial

The aim of the ACTIVATE trial is to evaluate the impact of a supervised aerobic exercise intervention on chemotherapy-related cognitive changes (CRCC) in women diagnosed with early stage breast cancer. Chemotherapy-related cognitive changes (CRCC) are reported by up to 75% of breast  cancer survivors during treatment and symptoms persist in 35% of survivors after treatment. Aerobic exercise is associated with improved quality of life in breast cancer survivors and holds promise as an intervention to prevent or mitigate CRCC.

We are recruiting women with breast cancer who are receiving adjuvant chemotherapy to participate in the ACTIVATE study. The exercise intervention includes 3x weekly supervised aerobic exercise training for 12-16 weeks. All exercise programs are individually-tailored and supervised by staff who have experience working with cancer patients. For more information please contact Kylie Sullivan at 519-803-3658 or email:

  • SIRvivor BC: Prostate Cancer Exercise Program

SIRvivor is a specialized exercise program that supports men living with prostate cancer. For more information, please click here.

  • Colon Health and Life-Long Exercise Change (CHALLENGE) Trial

The CO.21 Colon Health and Life-Long Exercise Change (CHALLENGE) trial undertaken by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) is designed to determine the effects of a structured physical activity intervention on outcomes for survivors of high-risk stage II or III colon cancer who have completed adjuvant therapy within the previous 2–6 months.  The trial is a multi-site trial across Canada and Australia.

The Trial is running at the BCCA-Vancouver site.  If you are being treated there for colon cancer and are interested in the trial, please talk to your oncologist.

For more information about the study, please click here.